Clinical Trial Update: Ixekizumab in the Treatment of Bullous Pemphigoid [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ixekizumab for bullous pemphigoid has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid
• Pemphigoid

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Bullous Pemphigoid, Pemphigoid | Phase 2 | Status: COMPLETED | Results posted: 2020-05-21